Yuan X, Li D, Wang K, Lauand F, et al. iGlarLixi effectively reduces residual hyperglycaemia in Chinese people with type 2 diabetes on basal insulin: A post hoc analysis of the LixiLan-L-CN study. Diabetes Obes Metab 2024 Oct 3. doi: 10.1111/dom.15968.
PMID: 39360440